Atractylenolide III predisposes miR‐195‐5p/FGFR1 signaling axis to exert tumor‐suppressive functions in liver cancer
Langqing Sheng(Central South University), Ze‐Guo Chen(Central South University), Ling Liu(Shanghai Medical College of Fudan University), Qi Zhang(Jiamusi University), Xiaoli Li(Fujian Medical University), Liansheng Gong(Central South University), Hui Luo(Jiangxi Provincial Cancer Hospital), Jiarong Li(Harbin Institute of Technology), Nianfeng Li(Central South University)
Cited by 18
Related Papers
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
|Oncogenesis|2016|259
Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
|Carcinogenesis|2013|256
Tunable Topological Phononic Crystals
|Physical Review Applied|2016|237